Aileron Therapeutics Inc. (ALRN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 9:00 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 17.31M | 5.19M | 3.60M | 7.05M | 5.31M | 10.63M | 11.86M | 20.71M | 3.77M | 6.21M | 9.95M |
Short-Term Investments | n/a | 16.05M | 42.33M | 6.76M | 12.97M | 10.06M | 38.89M | n/a | n/a | 10.01M | 4.12M |
Long-Term Investments | n/a | n/a | n/a | n/a | 568.00K | 568.00K | n/a | 63.00K | 63.00K | n/a | n/a |
Other Long-Term Assets | 2.19M | 24.00K | 24.00K | n/a | 568.00K | 679.00K | 694.00K | 778.00K | 1.50M | 63.00K | 780.00K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 953.00K | 631.00K | 2.24M | 2.52M | 1.27M | 1.08M | 1.09M | 358.00K | 258.00K | 862.00K | 300.00K |
Total Current Assets | 18.27M | 21.87M | 48.18M | 16.33M | 19.55M | 21.77M | 51.84M | 21.07M | 4.03M | 17.08M | 14.37M |
Property-Plant & Equipment | 19.00K | 110.00K | 280.00K | 15.00K | 6.36M | 7.29M | 154.00K | 107.00K | 351.00K | 582.00K | 953.00K |
Goodwill & Intangibles | 85.53M | n/a | n/a | n/a | -2.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 87.74M | 134.00K | 304.00K | 15.00K | 6.92M | 8.54M | 848.00K | 948.00K | 1.91M | 645.00K | 1.73M |
Total Assets | 106.01M | 22.01M | 48.48M | 16.34M | 26.47M | 30.31M | 52.69M | 22.02M | 5.94M | 17.73M | 16.11M |
Account Payables | 1.19M | 1.72M | 1.21M | 1.60M | 1.45M | 1.73M | 1.60M | 1.97M | 641.00K | 954.00K | 1.80M |
Deferred Revenue | n/a | n/a | n/a | n/a | 3.59M | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 48.00K | 66.00K | 186.00K | 168.00K | 892.00K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 3.15M | 1.60M | 3.11M | 2.20M | 3.50M | 3.64M | 3.29M | 2.10M | 1.91M | 1.16M | 2.47M |
Total Current Liabilities | 4.38M | 3.38M | 4.51M | 3.96M | 5.84M | 5.37M | 4.89M | 4.07M | 2.55M | 2.11M | 4.27M |
Long-Term Debt | n/a | n/a | 69.00K | 219.00K | 4.59M | 5.34M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 91.41M | n/a | n/a | n/a | n/a | n/a | n/a | 129.76M | 97.71M | n/a | n/a |
Total Long-Term Liabilities | 94.74M | 1.75M | 69.00K | 219.00K | 4.59M | 5.34M | n/a | 129.76M | 97.71M | n/a | n/a |
Total Liabilities | 99.12M | 3.38M | 4.58M | 4.18M | 10.43M | 10.71M | 4.89M | 133.83M | 100.26M | 2.11M | 4.27M |
Total Debt | 48.00K | 33.00K | 162.00K | 387.00K | 5.03M | 5.34M | n/a | n/a | n/a | n/a | n/a |
Common Stock | 91.00K | 91.00K | 91.00K | 44.00K | 28.00K | 15.00K | 15.00K | 4.00K | 4.00K | 4.00K | 4.00K |
Retained Earnings | -288.52M | -272.79M | -245.46M | -219.29M | -198.13M | -168.49M | -136.95M | -114.34M | -96.22M | -83.34M | -67.32M |
Comprehensive Income | -63.00K | -48.00K | -13.00K | -2.00K | 7.00K | -5.00K | -33.00K | -2.09M | -1.86M | 4.00K | 3.00K |
Shareholders Equity | 6.89M | 18.62M | 43.90M | 12.16M | 16.05M | 19.60M | 47.80M | -111.81M | -94.32M | 15.57M | 11.51M |
Total Investments | n/a | 16.05M | 42.33M | 6.76M | 12.97M | 10.06M | 38.89M | 63.00K | 63.00K | 10.01M | 4.12M |